Langzeitergebnisse der ABCSG-8A-Studie

Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom

This is a preview of subscription content, access via your institution.

Literatur

  1. 1.

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG) et al. Lancet. 2011;378(9804):1707-16

  2. 2.

    Kunkler IH et al. Lancet Oncol. 2015;16(3):266-73

  3. 3.

    Blamey RW et al. Eur J Cancer. 2013;49(10):2294-302

  4. 4.

    Fyles AW et al. N Engl J Med. 2004;351(10):963-70

  5. 5.

    Hughes KS et al. J Clin Oncol. 2013;31(19):2382-7

  6. 6.

    Pötter R et al. Int J Radiat Oncol Biol Phys. 2007;68(2):334-40

  7. 7.

    Tinterri C et al. Ann Surg Oncol. 2014;21(2):408-15

  8. 8.

    Matuschek C et al. Radiat Oncol. 2017;12(1):60

  9. 9.

    Bundesinstitut für Bevölkerungsforschung. 2020. https://www.bib.bund.de/Permalink.html?id=10262290 abgerufen am 4. November 2020

  10. 10.

    Borm KJ et al. Radiother Oncol. 2020;142:195-201

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Dr. med. David Krug or Marciana Nona Duma.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Krug, D., Duma, M. Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom . InFo Hämatol Onkol 23, 38–39 (2020). https://doi.org/10.1007/s15004-020-8307-x

Download citation